Association between Metabolic Syndrome and Its Components with Cardiovascular Disease Risk in the MASHAD Cohort Study Population

Association between Metabolic Syndrome and Its Components with Cardiovascular Disease Risk in the MASHAD Cohort Study Population

Introduction: The primary aim of this study was to evaluate the association of metabolic syndrome (MetS), based on different definitions, with the risk of total cardiovascular disease (CVD), unstable angina (UA), stable angina (SA), and myocardial infarction (MI). Additionally, we aimed to investiga...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Asadi, Hamideh Ghazizadeh, Ameneh Timar, Mohammad Amin Khodadadegan, Hamed Ghazavi, Mohammad Nasrabadi, Toktam Sahranavard, Mohammad Reza Fazl Mashhadi, Mohammad Amin Mohammadi, Arezoo Rastegar-Moghadam, Ali Ebrahimi Dabagh, Sara Moazedi, Shadi Kadkhoda-Ahmadi, Mohammad Reza Shadmand Foumani Moghadam, Mohanna Zakariaei-Saraji, Reza Zare-Feyzabadi, Fatemeh Sadabadi, Susan Darroudi, Afsane Bahrami, Habibollah Esmaily, Roshanak Ghaffarian Zirak, maryam Tayefi, Mohsen Moohebati, Alireza Heidari Bakavoli, Gordon A. Ferns, Majid Ghayour-Mobarhan
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-03-01
Series:Journal of Cardio-Thoracic Medicine
Subjects:
cardiovascular diseases
international diabetes federation
metabolic syndrome
national cholesterol education program adult treatment panel iii
world health organization
Online Access:https://jctm.mums.ac.ir/article_25753_780058fa216bce6b54bf1be2c4631eb3.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: The primary aim of this study was to evaluate the association of metabolic syndrome (MetS), based on different definitions, with the risk of total cardiovascular disease (CVD), unstable angina (UA), stable angina (SA), and myocardial infarction (MI). Additionally, we aimed to investigate which definition of MetS is a better predictor of CVD events in a large sample of Iranian adults.Methods: The analysis was conducted among 7,910 adults from the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) cohort study. The presence of MetS at baseline was defined using the following criteria: International Diabetes Federation (IDF 2005), National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), and World Health Organization (WHO). Hazard ratios (HR) and 95% confidence intervals (CI) were used to estimate the association of MetS and its components with CVD events.Results: The prevalence of MetS among CVD patients was 56.40%, 52.30%, and 23.90% based on the IDF, NCEP ATP III, and WHO criteria, respectively. The highest HR for total CVD (HR: 2.29; 95% CI: 1.54–3.40; P<0.001), UA (HR: 2.13; 95% CI: 1.22 – 3.72; P<0.01), and MI (HR: 3.11; 95% CI: 1.33–7.26; P<0.01) was found when using the WHO definition. The highest HR for SA (HR: 2.56; 95% CI: 1.37 – 4.81; P<0.001) was found when using the NCEP ATP III definition.Conclusion: Having MetS based on the WHO definition was a significant predictor for the incidence of total CVD, MI, and UA, while having MetS based on the ATP III criteria was associated with a higher risk of SA in the MASHAD study population.
ISSN:2345-2447
2322-5750

Similar Items